Purchase Order 75N92019P00192

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $49,900 on January 24, 2020, for acquisition of a Missionbio single-cell multi-omics platform for an AML lab. Performance takes place in South San Francisco, California. The order is firm fixed price with an ultimate completion date of February 23, 2020.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for $49,900 on January 24, 2020, for acquisition of a Missionbio single-cell multi-omics platform for the CLL Lab. Performance occurs in South San Francisco, California. The order is firm fixed price with an ultimate completion date of February 23, 2020.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for Tapestri Single-Cell Kits valued at $26,400 on September 18, 2018. Work is performed in South San Francisco, California. The order covers single-cell DNA and protein sequencing reagent kits supporting biomedical research. Ultimate completion is November 30, 2018. The procurement was issued under a special notice without a small business set-aside.</p>

Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...

<p>The National Heart Lung and Blood Institute issued a $9,947.04 delivery order to Illumina, Inc. on July 12, 2017, for DNA sequencing kits to be used for genetic analysis of human immunological cells from patient samples collected over several months.</p> <p>Place of performance is San Diego, CA 92122. Ultimate completion date is September 2, 2020. The order is priced on a firm fixed-price basis with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued an $82,024.32 delivery order to Illumina, Inc. on August 6, 2020, for Illumina sequencing kits and reagents supporting next-generation sequencing on Illumina instruments at the NHLBI Sequencing Core Facility.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020.</p>

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,105.91 firm fixed price delivery order to Illumina, Inc. to provide DNA sequencing and genomics core requirements including Illumina library preparation kits. The place of performance is San Diego, California. The period of performance is from June 30, 2023 through September 29, 2023. The award supports the agency's biomedical research efforts by providing key...

The National Heart Lung and Blood Institute issued a $106,101.30 delivery order to Illumina, Inc. on September 2, 2026, for next-generation sequencing kits and reagents to support the NHLBI Sequencing Core Facility. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of September 2, 2026. The delivery order procures Illumina sequencing kits and reagents required to conduct next-generation sequencing on Illumina instruments for supported...

<p>The National Heart Lung and Blood Institute issued a $45,211.40 delivery order to Illumina, Inc. on June 24, 2020, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used. The source does not identify a parent IDIQ or GWAC vehicle for this delivery order.</p>

<p>The National Heart Lung and Blood Institute issued a $31,987.71 delivery order to Illumina, Inc. on May 23, 2019, for genetic sequencing and genomic analysis equipment and services, with ultimate completion by September 2, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed-price with no set-aside designation.</p>